NEW YORK (TheStreet) -- In light of BB&T Corp.'s (BBT) - Get Reportagreement announced last month to acquire Susquehanna Bancshares (SUSQ) , here are some technical trading guidelines for seven regional banks, including BB&T.

BB&T ($37.41) set a multiyear intraday high at $41.04 on March 26, and then declined 16% to $34.50 on Oct. 16. It is below its 200-day simple moving average of $37.98. Investors should enter a good 'til canceled limit order to buy on weakness to the 200-week SMA at $31.59. Investors who are looking to book profits should enter a good 'til canceled limit order to sell on strength at a key technical level of $38.45.

Fifth Third Bancorp  (FITB) - Get Report ($19.92) set a multiyear intraday high at $23.90 on March 21, and then declined 26% to $17.65 on Oct. 16. It's below its 200-day SMA of $20.82. Investors should enter a good 'til canceled limit order to buy on weakness at the 200-week SMA of $16.38. Investors who are looking to book profits should enter a good 'til canceled limit order to sell on strength at key technical levels of $21.25 and $23.20.

M&T Bank (MTB) - Get Report ($125.72) set an all-time intraday high of $128.69 on Sept.19, and then declined 13% to $112.42 on Oct. 20. It's above its 200-day SMA of $121.59. Investors should enter a good 'til canceled limit order to buy on weakness at the 200-week SMA of $99.89. Investors who are looking to book profits should enter a good 'til canceled limit order to sell on strength at a key technical level of $135.85.

PNC Financial (PNC) - Get Report ($87.50) set an all-time intraday high of $90 on July 3, and then declined 15% to $76.69 on Oct. 16. It's above its 200-day SMA at $84.91. Investors should enter a good 'til canceled limit order to buy on weakness at the 200-week SMA of $68.10. Investors who are looking to book profits should enter a good 'til canceled limit order to sell on strength at a key technical level of $91.95.

Regions Financial (RF) - Get Report ($9.86) set a multiyear intraday high of $11.54 on March 21, and declined 23% to $8.85 on Oct. 15. It's below its 200-day SMA of $10.27. Investors should enter a good 'til canceled limit order to buy on weakness at the 200-week SMA of $7.85. Investors who are looking to book profits should enter a good 'til canceled limit order to sell on strength at a key technical level of $11.95.

SunTrust Banks (STI) - Get Report ($39.39) set a multiyear intraday high at $41.25 on March 21, and declined 18% to $33.97 on Oct. 16. It's above its 200-day SMA of $38.64. Investors should enter a good 'til canceled limit order to buy weakness at the 200-week SMA of $29.70. Investors who are looking to book profits should enter a good 'til canceled limit order to sell on strength at a key technical level of $41.60.

U.S. Bancorp (USB) - Get Report ($44.07) set its 2014 low at $38.10 on Oct.16, which was down 13% from $43.58 on Sept.10. The stock then rebounded 17% to an all-time intraday high of $44.68 on Nov. 28, and it's now above its 200-day SMA of $42.01. Investors should enter a good 'til canceled limit order to buy on weakness at the 200-week SMA of $33.76. Investors who are looking to book profits should enter a good 'til canceled limit order to sell strength at a key technical level of $45.75.

This article is commentary by an independent contributor, separate from TheStreet's regular news coverage.

Follow @Suttmeier

TheStreet Ratings team rates BB&T CORP as a Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:

"We rate BB&T CORP (BBT) a BUY. This is driven by multiple strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, good cash flow from operations, expanding profit margins, increase in stock price during the past year and impressive record of earnings per share growth. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook."

You can view the full analysis from the report here: BBT Ratings Report

At the time of publication, the author held no positions in any of the stocks mentioned.